• Molecular NameDactinomycin
  • SynonymAD; Antibiotic From Streptomyces Parvullus; Dactinomicina [INN-Spanish]; Dactinomycine [INN-French]; Dactinomycinum [INN-Latin]
  • Weight1255.44
  • Drugbank_IDDB00970
  • ACS_NO50-76-0
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)N/A
  • pkaN/A
  • LogD (pH=7, predicted)N/A
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)N/A
  • LogSw (predicted, AB/LogsW2.0)N/A
  • Sw (mg/ml) (predicted, ACD/Labs)N/A
  • No.of HBond DonorsN/A
  • No.of HBond AcceptorsN/A
  • No.of Rotatable BondsN/A
  • TPSAN/A
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA class of polypeptide antibiotics isolated from soil bacteria of the genus Streptomyces, of which the most significant is actinomycin D.
  • Absorption_valueN/A
  • Absorption (description)Dactinomycin is rapidly distributed following intravenous administration and concentrates in bone marrow and nucleated cells.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmThe drug undergoes minimal metabolism
  • Half life36 h
  • ExcretionSlowly excreted in urine (about 10% as unchanged drug) and via bile in faeces (about 50% as the unchanged drug).
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A